Member Info for Formul1187

TexRAD Limited - use of Intellectual property
Stone Checker's ability to exploit its products is reliant upon the terms of an exclusive licence from TexRAD Limited which grants Stone Checker the right to use the TexRAD's Patents in the field of urolithiasis and to research, develop or have developed, make or have made, keep, use, import, export, sell and supply products based upon the TexRAD Plug-in pursuant to the terms of a licence agreement dated 20 August 2015.

TexRAD may terminate this agreement under a number of circumstances, which would prevent Stone Checker being able to develop and sell its products.

Contract news will be in the result’s, Mr Millen has a funny way of producing his Rns’s!!

Hoping they missed the punch line. New rns will put the books straight I’ll be hovering over the buy button Gla dyor!!

is do we stay invested & top up or hit the sell button, cant really some up the bod's decision to release the rns in that context ?

StoneChecker is medical imaging software used to measure key kidney stone parameters to
generate a set of textual metrics. It uses an application (TexRAD, licensed by Feedback Medical Ltd)
that analyses the texture in an existing radiological scan. The aim is to help clinicians assess a
stone's heterogeneity and any characteristics not visible to the naked eye. It creates a visual 'map'
of a kidney stone.
The technology is designed to be used with conventional CT scans to help clinical decision making
about diagnosing and treating people with kidney stones. It imports imaging data and calculates
metrics based on individual pixel data points within a given region of interest. These metrics assess
stone heterogeneity, including texture irregularity, not provided by conventional CT scans. The
technology can also use filters to extract and enhance existing CT images to help assess stone
composition. This can potentially be used to predict treatment failure on pre-treatment CT, and to
identify and select patients who are most likely to benefit from the treatment.
StoneChecker software runs on existing Windows-based machines or workstations, and can be
integrated with a hospital picture archiving and communication system to import files containing
CT images.
Innovations
StoneChecker uses an algorithm aimed at measuring the size and volume of kidney stones. It can
also assess stone heterogeneity using filtration-histogram-based texture analysis, which enhances
the details seen with conventional CT. Currently, there is no standardised method of measuring the
physical and texture parameters that enable clinicians to predict treatment outcomes.

Worth a read !!

Proven!!!

Could be possible

That’s confidence

Massive upside!!

Now she’s on the move !! Did say ticking up !! By the way was born in gujarat !!!

Well said this is massive upside great things to come !! Onwards & upwards!!

Flash Gordon

Oilex is laughing now bring it on ££££&££££

Tick up & news lol

Going to tick up again!!

Sells getting mopped up!!

Cracking news oh well onwards & upwards!!

For trying to de ramp this stock! Onward & upwards!!!

Cambay field is a giant just a smell of 1 tcf could propel this in to the the oblivion!!! Gla